Page last updated: 2024-09-02

fingolimod hydrochloride and Gastritis

fingolimod hydrochloride has been researched along with Gastritis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bromberg, JS; Chen, D; Ding, Y; Fu, S; Mao, M; Mao, X; Yopp, AC; Zhang, N1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Gastritis

ArticleYear
CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:1

    Topics: Animals; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Division; Cell Movement; Cell Separation; Chemokine CCL19; Chemokine CCL2; Chemokines, CC; Chemotaxis; Colitis; Cytokines; Enzyme-Linked Immunosorbent Assay; Fingolimod Hydrochloride; Flow Cytometry; Gastritis; L-Selectin; Lymphocyte Subsets; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Phenotype; Propylene Glycols; Receptors, CCR2; Receptors, CCR7; Receptors, Chemokine; Receptors, Interleukin-2; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine; T-Lymphocytes; Time Factors

2004